Square Pharmaceuticals PLC. announcements
313 Dhaka Stock Exchange announcements for Square Pharmaceuticals PLC. (SQURPHARMA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (23).
- Credit Rating Result
Credit Rating Information and Services Limited (CRISL) has assigned the rating of the Company as "AAA" in the long term and "ST-1" in the short term along with Stable outlook in consideration of its audited financials up to June 30, 2024; unaudited financials up to September 30, 2024 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Resumption after Record Date
Trading of the shares of the company will resume on 24.11.2024.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 21.11.2024.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 19.11.2024 to 20.11.2024 and trading of the shares will remain suspended on record date i.e., 21.11.2024.
- Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 6.87 for July-September 2024 as against Tk. 6.77 for July-September 2023; Consolidated NOCFPS was Tk. 3.89 for July-September 2024 as against Tk. 9.54 for July-September 2023. Consolidated NAV per share was Tk. 149.76 as on September 30, 2024 and Tk. 142.05 as on June 30, 2024.
- Transmission of shares of Mrs. Anita Chowdhury
The company has informed that a total of 66,052,814 shares of Mrs. Anita Chowdhury, mother of the following Directors of the company, has been transmitted to her legal heirs as per the Succession Certificate issued by the Honorable Court. The shares have been transmitted as follows: (cont.) (Cont. news of SQURPHARMA): Mr. Samuel S Chowdhury, Chiarman (son), received 16,513,203 shares; Mrs. Ratna Patra, Vice Chairman (daughter), received 16,513,205 shares; Mr. Tapan Chowdhury, Managing Director (son), received 16,513,203 shares; and Mr. Anjan Chowdhury, Director (son), received 16,513,203 shares. (end)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
- The Board of Directors has recommended 110\% Cash Dividend for the year ended June 30, 2024. Date of AGM: 18.12.2024, Ti
The Board of Directors has recommended 110\% Cash Dividend for the year ended June 30, 2024. Date of AGM: 18.12.2024, Time: 10:00 AM, Venue: Virtual Platform. Record Date: 21.11.2024. The Company has also reported Consolidated EPS of Tk. 23.61, Consolidated NAV per share of Tk. 142.05 and Consolidated NOCFPS of Tk. 20.90 for the year ended June 30, 2024 as against Tk. 21.41, Tk. 129.95 and Tk. 9.64 respectively for the year ended June 30, 2023. (cont.)
- Dividend Declaration
(Continuation news of SQURPHARMA): The company has also informed that the Board of Directors of the company has approved Tk. 500 crore for BMRE, Capital Machineries and Land (for the purpose of future extension). (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (24.10.2024) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 23, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- Buy Confirmation of a Director
Mr. Samuel S Chowdhury, one of the Directors of the Company, has further informed that he has completed his buying of 2,000,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 21.03.2024.
- Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 5.55 for January-March 2024 as against Tk. 4.83 for January-March 2023; Consolidated EPS was Tk. 18.24 for July 2023-March 2024 as against Tk. 16.82 for July 2022-March 2023. Consolidated NOCFPS was Tk. 17.32 for July 2023-March 2024 as against Tk. 10.95 for July 2022-March 2023. Consolidated NAV per share was Tk. 137.39 as on March 31, 2024 and Tk. 129.95 as on June 30, 2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2024 at 03:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2024.
- Buy Confirmation of a Director
Mr. Tapan Chowdhury, a Director of the Company, has further informed that he has completed his buying of 20,00,000 shares of the company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated on 11.03.2024.
- Buy Declaration of a Director
Mr. Samuel S Chowdhury, one of the Directors of the Company, has expressed his intention to buy 2,000,000 shares of the company at prevailing market price (in the Public and Block Market) through Dhaka Stock Exchange PLC. within April 30, 2024.
- Buy Declaration of a Director
Mr. Tapan Chowdhury, one of the Directors of the Company, has expressed his intention to buy 20,00,000 shares of the company at prevailing market price (in the Public and Block Market) through Dhaka Stock Exchange PLC. within next 30 working days.
- Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 5.92 for October-December 2023 as against Tk. 5.78 for October-December 2022; Consolidated EPS was Tk. 12.69 for July-December 2023 as against Tk. 11.99 for July-December 2022. Consolidated NOCFPS was Tk. 14.37 for July-December 2023 as against Tk. 8.32 for July-December 2022. Consolidated NAV per share was Tk. 132.07 as on December 31, 2023 and Tk. 129.95 as on June 30, 2023.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2023 to the respective shareholders.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 31, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.
- Mr. Samuel S Chowdhury, one of the Directors of the Company, has further informed that he has completed his buying of 1,
Mr. Samuel S Chowdhury, one of the Directors of the Company, has further informed that he has completed his buying of 1,000,000 shares of the company at prevailing market price through Dhaka Stock Exchange Limited as per declaration disseminated on 05.12.2023.
- Mr. Tapan Chowdhury, one of the Directors of the Company, has further informed that he has completed his buying of 1,000
Mr. Tapan Chowdhury, one of the Directors of the Company, has further informed that he has completed his buying of 1,000,000 shares of the company at prevailing market price through Dhaka Stock Exchange Limited as per declaration disseminated on 03.12.2023.
- Buy Confirmation of a Director
Mrs. Ratna Patra, one of the Directors of the Company, has further informed that she has completed her buying of 1,000,000 shares of the company at prevailing market price through Dhaka Stock Exchange Limited as per declaration disseminated on 03.12.2023.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.